litlas
Log inCreate account

Mark A. Geyer

Active 1972–2021

Also published as
Mark A Geyer
187
Papers
37,305
Citations
114
h-index
187
i10-index

Citations

Citations per year for Mark A. Geyer1932: 1 citations1974: 4 citations1975: 4 citations1976: 8 citations1977: 11 citations1978: 19 citations1979: 12 citations1980: 14 citations1981: 11 citations1982: 4 citations1983: 3 citations1984: 10 citations1985: 2 citations1986: 17 citations1987: 16 citations1988: 13 citations1989: 19 citations1990: 62 citations1991: 56 citations1992: 75 citations1993: 108 citations1994: 111 citations1995: 141 citations1996: 102 citations1997: 132 citations1998: 210 citations1999: 308 citations2000: 292 citations2001: 393 citations2002: 310 citations2003: 402 citations2004: 282 citations2005: 309 citations2006: 429 citations2007: 321 citations2008: 452 citations2009: 373 citations2010: 317 citations2011: 437 citations2012: 318 citations2013: 312 citations2014: 338 citations2015: 262 citations2016: 325 citations2017: 228 citations2018: 151 citations2019: 680 citations2020: 707 citations2021: 577 citations2022: 454 citations2023: 359 citations2024: 488 citations2025: 162 citations2026: 9 citations1933–1973: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 3,232 citing papers, 35% of this breakdownUnited Kingdom: 750 citing papers, 8.1% of this breakdownGermany: 502 citing papers, 5.4% of this breakdownCanada: 471 citing papers, 5.1% of this breakdownAustralia: 324 citing papers, 3.5% of this breakdownSwitzerland: 323 citing papers, 3.5% of this breakdownChina: 322 citing papers, 3.5% of this breakdownNetherlands: 300 citing papers, 3.3% of this breakdownItaly: 298 citing papers, 3.2% of this breakdownFrance: 285 citing papers, 3.1% of this breakdownJapan: 244 citing papers, 2.7% of this breakdownSpain: 192 citing papers, 2.1% of this breakdown
0%35%Other 21.5%

Institutions

Fields

  • Neuroscience42.7%
  • Medicine19.9%
  • Psychology16.7%
  • Biochemistry, Genetics and Molecular Biology14.5%
  • Computer Science1.2%
  • Pharmacology, Toxicology and Pharmaceutics1%
  • Other4%

Topics

  • Neurotransmitter Receptor Influence on Behavior8.9%
  • Neuroscience and Neuropharmacology Research6.1%
  • Stress Responses and Cortisol4.2%
  • Tryptophan and brain disorders4%
  • Receptor Mechanisms and Signaling3.9%
  • Neuroendocrine regulation and behavior3.8%
  • Other69.1%

Coauthors

All papers

Open in search
  1. Habituation revisited: An updated and revised description of the behavioral characteristics of habituation

    Authors: Catharine H. Rankin, Thomas W. Abrams, Robert J. Barry, Seema Bhatnagar, David F. Clayton, John Colombo, Gianluca Coppola, Mark A. Geyer, David L. Glanzman, Stephen Marsland, Frances K. McSweeney, Donald A. Wilson, Chun-Fang Wu, Richard F. Thompson - Neurobiology of Learning and Memory 2008 cited by 1,669

  2. Cognitive dysfunction in psychiatric disorders: characteristics, causes and the quest for improved therapy

    Authors: Mark J. Millan, Yves Agid, Martin Brüne, Edward T. Bullmore, Cameron S. Carter, Nicola S. Clayton, Richard C. Connor, Sabrina Davis, J.F.W. Deakin, Robert J. DeRubeis, Bruno Dubois, Mark A. Geyer, Guy M. Goodwin, Philip Gorwood, Thérèse M. Jay, Marian Joëls, Isabelle M. Mansuy, Andreas Meyer‐Lindenberg, Declan Murphy, Edmund T. Rolls, B. Saletu, Michael Spedding, John A. Sweeney, Miles A. Whittington, Larry J. Young - Nature Reviews Drug Discovery 2012 cited by 1,297

  3. Multiple receptors contribute to the behavioral effects of indoleamine hallucinogens

    Authors: Adam L. Halberstadt, Mark A. Geyer - Neuropharmacology 2011 cited by 418

  4. Differential contributions of serotonin receptors to the behavioral effects of indoleamine hallucinogens in mice

    Authors: Adam L. Halberstadt, Liselore Koedood, Susan B. Powell, Mark A. Geyer - Journal of Psychopharmacology 2010 cited by 212

  5. Characterization of the head-twitch response induced by hallucinogens in mice

    Authors: Adam L. Halberstadt, Mark A. Geyer - Psychopharmacology 2013 cited by 216

  6. Psilocybin-Induced Deficits in Automatic and Controlled Inhibition are Attenuated by Ketanserin in Healthy Human Volunteers

    Authors: Boris B. Quednow, Michael Kometer, Mark A. Geyer, Franz X. Vollenweider - Neuropsychopharmacology 2011 cited by 241

  7. A systems model of altered consciousness: integrating natural and drug-induced psychoses

    Authors: Franz X. Vollenweider, Mark A. Geyer - Brain Research Bulletin 2001 cited by 348

  8. Convergent functional genomics of schizophrenia: from comprehensive understanding to genetic risk prediction

    Authors: Mohammed Ayalew, H Le-Niculescu, Daniel F. Levey, Neha Jain, B Changala, Sagar D. Patel, Evan A. Winiger, Alan Breier, Anantha Shekhar, Richard Amdur, Daphne Koller, John I. Nürnberger, Aiden Corvin, Mark A. Geyer, Ming T. Tsuang, Daniel R. Salomon, Nicholas J. Schork, Ayman H. Fanous, Michael O‘Donovan, Alexander B. Niculescu - Molecular Psychiatry 2012 cited by 406

  9. Pharmacological and Behavioral Profile of N-(4-Fluorophenylmethyl)-N-(1-methylpiperidin-4-yl)-N′-(4-(2-methylpropyloxy)phenylmethyl) Carbamide (2 R,3 R)-Dihydroxybutanedioate (2:1) (ACP-103), a Novel 5-Hydroxytryptamine2A Receptor Inverse Agonist

    Authors: Kimberly E. Vanover, David M. Weiner, Malath Makhay, Isaac Veinbergs, Luis R. Gardell, Jelveh Lameh, Andria L. Del Tredici, Fabrice Piu, Hans H. Schiffer, Thomas Ott, Ethan S. Burstein, Allan K Uldam, Mikkel B. Thygesen, Nathalie Schlienger, Carl Magnus Andersson, Thomas Son, Scott C. Harvey, Susan B. Powell, Mark A. Geyer, Bo-Ragner Tolf, Mark R. Brann, Robert E. Davis - Journal of Pharmacology and Experimental Therapeutics 2006 cited by 203

  10. Effect of Hallucinogens on Unconditioned Behavior

    Authors: Adam L. Halberstadt, Mark A. Geyer - Current topics in behavioral neurosciences 2016 cited by 102

  11. Human studies of prepulse inhibition of startle: normal subjects, patient groups, and pharmacological studies

    Authors: David Braff, Mark A. Geyer, Neal R. Swerdlow - Psychopharmacology 2001 cited by 1,724

  12. Serotonin research: contributions to understanding psychoses

    Authors: Mark A. Geyer, Franz X. Vollenweider - Trends in Pharmacological Sciences 2008 cited by 435

  13. The Effects of the Preferential 5-HT2A Agonist Psilocybin on Prepulse Inhibition of Startle in Healthy Human Volunteers Depend on Interstimulus Interval

    Authors: Franz X. Vollenweider, Philipp Csomor, Bernhard Knappe, Mark A. Geyer, Boris B. Quednow - Neuropsychopharmacology 2007 cited by 194

  14. 5-HT2A and 5-HT2C Receptors Exert Opposing Effects on Locomotor Activity in Mice

    Authors: Adam L. Halberstadt, Iris van der Heijden, Michael A. Ruderman, Victoria B. Risbrough, Jay A. Gingrich, Mark A. Geyer, Susan B. Powell - Neuropsychopharmacology 2009 cited by 174

  15. Genetic loci associated with heart rate variability and their effects on cardiac disease risk

    Authors: Ilja M. Nolte, M. Loretto Muñoz, Vinicius Tragante, Azmeraw T. Amare, Rick Jansen, Ahmad Vaez, Benedikt von der Heyde, Christy L. Avery, Joshua C. Bis, Bram Dierckx, Jenny van Dongen, Stephanie M. Gogarten, Philippe Goyette, Jussi Hernesniemi, Ville Huikari, Shih-Jen Hwang, Deepali Jaju, Kathleen F. Kerr, Alexander Kluttig, Bouwe P. Krijthe, Jitender Kumar, Sander W. van der Laan, Leo‐Pekka Lyytikäinen, Adam X. Maihofer, Arpi Minassian, Peter J. van der Most, Martina Müller‐Nurasyid, Michel G. Nivard, Erika Salvi, James D. Stewart, Julian F. Thayer, Niek Verweij, Andrew Wong, Delilah Zabaneh, Mohammad Hadi Zafarmand, Abdel Abdellaoui, Sulayma Albarwani, Christine M. Albert, Álvaro Alonso, Foram N. Ashar, Juha Auvinen, Tomas Axelsson, Dewleen G. Baker, Paul I. W. de Bakker, Matteo Barcella, Riad Bayoumi, Rob J. Bieringa, Dorret I. Boomsma, Gabrielle Boucher, Annie Britton, Ingrid E. Christophersen, Andrea Dietrich, G. Ehret, Patrick T. Ellinor, Markku Eskola, Janine F. Felix, John S. Floras, Oscar H. Franco, Peter Friberg, Maaike G. J. Gademan, Mark A. Geyer, Vilmantas Giedraitis, Catharina A. Hartman, Daiane Hemerich, Albert Hofman, Jouke‐Jan Hottenga, Heikki V. Huikuri, Nina Hutri‐Kähönen, Xavier Jouven, Juhani Junttila, Markus Juonala, Antti M. Kiviniemi, Jan A. Kors, Meena Kumari, Tatiana Kuznetsova, Cathy C. Laurie, Joop D. Lefrandt, Yong Li, Yun Li, Duanping Liao, Marian C. Limacher, Henry J. Lin, Cecilia M. Lindgren, Steven A. Lubitz, Anubha Mahajan, Barbara McKnight, Henriette E. Meyer zu Schwabedissen, Yuri Milaneschi, Nina Mononen, Andrew P. Morris, Mike A. Nalls, Gerjan Navis, Melanie Neijts, Kjell Nikus, Kari E. North, Daniel T. O’Connor, Johan Ormel, Siegfried Perz, Annette Peters, Bruce M. Psaty and 64 more - Nature Communications 2017 cited by 164

  16. The roles of 5-HT1A and 5-HT2 receptors in the effects of 5-MeO-DMT on locomotor activity and prepulse inhibition in rats

    Authors: Kirsten Krebs-Thomson, Erbert M. Ruiz, Virginia L. Masten, Mahálah R. Buell, Mark A. Geyer - Psychopharmacology 2006 cited by 96

  17. Neural circuit regulation of prepulse inhibition of startle in the rat: current knowledge and future challenges

    Authors: Neal R. Swerdlow, Mark A. Geyer, David Braff - Psychopharmacology 2001 cited by 1,065

  18. Removing Obstacles in Neuroscience Drug Discovery: The Future Path for Animal Models

    Authors: Athina Markou, Cristiano Chiamulera, Mark A. Geyer, Mark D. Tricklebank, Thomas Steckler - Neuropsychopharmacology 2008 cited by 324

  19. Analysis of Genetically Regulated Gene Expression Identifies a Prefrontal PTSD Gene, SNRNP35, Specific to Military Cohorts

    Authors: Laura M. Huckins, Chris Chatzinakos, Michael S. Breen, Jakob Hartmann, Torsten Klengel, Ana Carolina da Silva Almeida, Amanda Dobbyn, Kiran Girdhar, Gabriel E. Hoffman, Claudia Klengel, Mark W. Logue, Adriana Lori, Adam X. Maihofer, Filomene G. Morrison, Hoang T. Nguyen, Yongjin Park, Douglas M. Ruderfer, Laura Sloofman, Sanne J.H. van Rooij, Dewleen G. Baker, Chia‐Yen Chen, Nancy J. Cox, Laramie E. Duncan, Mark A. Geyer, Stephen J. Glatt, Hae Kyung Im, Victoria B. Risbrough, Jordan W. Smoller, Dan J. Stein, Rachel Yehuda, Israel Liberzon, Karestan C. Koenen, Tanja Jovanović, Manolis Kellis, Mark W. Miller, Silviu‐Alin Bacanu, Caroline M. Nievergelt, Joseph D. Buxbaum, Pamela Sklar, Kerry J. Ressler, Eli A. Stahl, Nikolaos P. Daskalakis - Cell Reports 2020 cited by 68

  20. Prestimulus Effects on Human Startle Reflex in Normals and Schizophrenics

    Authors: David Braff, C. Stone, Enoch Callaway, Mark A. Geyer, Ira Glick, Likh Bali - Psychophysiology 1978 cited by 1,178

  21. Prepulse inhibition and genetic mouse models of schizophrenia

    Authors: Susan B. Powell, Xianjin Zhou, Mark A. Geyer - Behavioural Brain Research 2009 cited by 218

  22. Sensorimotor gating of the startle reflex: what we said 25 years ago, what has happened since then, and what comes next

    Authors: Neal R. Swerdlow, David Braff, Mark A. Geyer - Journal of Psychopharmacology 2016 cited by 189

  23. Tactile prepuff inhibition of startle in children with Tourette’s syndrome: in search of an “fMRI-friendly” startle paradigm

    Authors: Neal R. Swerdlow, Blythe Karban, Yvonne Ploum, Richard F. Sharp, Mark A. Geyer, Angela Eastvold - Biological Psychiatry 2001 cited by 184

  24. Using an Animal Model of Deficient Sensorimotor Gating to Study the Pathophysiology and New Treatments of Schizophrenia

    Authors: Neal R. Swerdlow, Mark A. Geyer - Schizophrenia Bulletin 1998 cited by 617